EP1858923A4 - Molécule et molécules chimères de celle-ci - Google Patents

Molécule et molécules chimères de celle-ci

Info

Publication number
EP1858923A4
EP1858923A4 EP06704867A EP06704867A EP1858923A4 EP 1858923 A4 EP1858923 A4 EP 1858923A4 EP 06704867 A EP06704867 A EP 06704867A EP 06704867 A EP06704867 A EP 06704867A EP 1858923 A4 EP1858923 A4 EP 1858923A4
Authority
EP
European Patent Office
Prior art keywords
molecule
chimeric molecules
chimeric
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06704867A
Other languages
German (de)
English (en)
Other versions
EP1858923A1 (fr
Inventor
John D Priest
Alan D Watts
Jason S Whittaker
Teresa A Domagala
Carol M Y Lee
Raina J Simpson
Ingrid Boehm
Stuart Jackson
Catherine A Liddell
Glenn R Pilkington
Melissa Corbett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apollo Life Science Ltd
Original Assignee
Apollo Life Science Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005906337A external-priority patent/AU2005906337A0/en
Application filed by Apollo Life Science Ltd filed Critical Apollo Life Science Ltd
Publication of EP1858923A1 publication Critical patent/EP1858923A1/fr
Publication of EP1858923A4 publication Critical patent/EP1858923A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP06704867A 2005-02-14 2006-02-14 Molécule et molécules chimères de celle-ci Withdrawn EP1858923A4 (fr)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US65328505P 2005-02-14 2005-02-14
US65401705P 2005-02-16 2005-02-16
US66251705P 2005-03-15 2005-03-15
US66246605P 2005-03-15 2005-03-15
US67556705P 2005-04-27 2005-04-27
US67950405P 2005-05-10 2005-05-10
US68037505P 2005-05-12 2005-05-12
AU2005906337A AU2005906337A0 (en) 2005-11-15 Interleukin 10 and chimeric molecule thereof
AU2005906549A AU2005906549A0 (en) 2005-11-23 Interleukin 10 receptor alpha and chimeric molecules thereof
PCT/AU2006/000190 WO2006084337A1 (fr) 2005-02-14 2006-02-14 Molécule et molécules chimères de celle-ci

Publications (2)

Publication Number Publication Date
EP1858923A1 EP1858923A1 (fr) 2007-11-28
EP1858923A4 true EP1858923A4 (fr) 2008-10-15

Family

ID=36792855

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06704867A Withdrawn EP1858923A4 (fr) 2005-02-14 2006-02-14 Molécule et molécules chimères de celle-ci

Country Status (4)

Country Link
EP (1) EP1858923A4 (fr)
JP (1) JP2008536477A (fr)
CA (1) CA2597346A1 (fr)
WO (1) WO2006084337A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202090838A1 (ru) * 2017-09-27 2020-08-28 Эписентарикс, Инк. Иммуномодулирующие слитые белки
US20220144911A1 (en) * 2019-02-01 2022-05-12 Uab Research Foundation Methods and compositions for il10 signaling antagonism
KR20230121836A (ko) * 2020-12-18 2023-08-21 글리콤 에이/에스 하전된 올리고사카라이드의 분리

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1213004A (zh) * 1997-09-29 1999-04-07 成都拜奥生物技术研究所 重组白细胞介素－2腺病毒载体及产生方法
US20040019923A1 (en) * 1997-10-16 2004-01-29 Ivarie Robert D. Exogenous proteins expressed in avians and their eggs
ATE522548T1 (de) * 2003-11-13 2011-09-15 Hanmi Holdings Co Ltd Verfahren zur massenproduktion der konstanten region von immunglobulin

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO2006084337A1 *

Also Published As

Publication number Publication date
EP1858923A1 (fr) 2007-11-28
JP2008536477A (ja) 2008-09-11
CA2597346A1 (fr) 2006-08-17
WO2006084337A1 (fr) 2006-08-17

Similar Documents

Publication Publication Date Title
EP1844069A4 (fr) Molécules et leurs molécules chimériques
EP1844068A4 (fr) Molécules et leurs molécules chimériques
GB0601513D0 (en) Binding molecules 3
IL182139A0 (en) MODIFIED Fc MOLECULES
EP1959958A4 (fr) Petites molecules de liaison a une integrine
IL184467A0 (en) Cripto binding molecules
GB0618345D0 (en) Binding molecules
EP1856147A4 (fr) Molécule et molécules chimères de celle-ci
EP1861423A4 (fr) Molécule et molécules chimères de celle-ci
GB0601511D0 (en) Binding Molecules 2
GB0512225D0 (en) Immunoglobulin molecules
EP1858923A4 (fr) Molécule et molécules chimères de celle-ci
GB0410983D0 (en) Molecules
GB0521509D0 (en) Organic molecules
AU2005906599A0 (en) A molecule and chimeric molecules thereof
GB0406342D0 (en) Molecules
AU2006905487A0 (en) A molecule and chimeric molecules thereof
AU2006903976A0 (en) A molecule and chimeric molecules thereof
AU2006905880A0 (en) A molecule and chimeric molecules thereof
AU2006903473A0 (en) A molecule and chimeric molecules thereof
AU2006901044A0 (en) A molecule and chimeric molecules thereof
AU2006903503A0 (en) A molecule and chimeric molecules thereof
AU2006902647A0 (en) A molecule and chimeric molecules thereof
AU2006904641A0 (en) A molecule and chimeric molecules thereof
AU2006906886A0 (en) A molecule and chimeric molecules thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070911

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: WHITTAKER, JASON, S.

Inventor name: CORBETT, MELISSA

Inventor name: DOMAGALA, TERESA A

Inventor name: LIDDELL, CATHERINE A

Inventor name: JACKSON, STUART

Inventor name: PRIEST, JOHN D

Inventor name: PILKINGTON, GLENN, R.

Inventor name: BOEHM, INGRID

Inventor name: SIMPSON, RAINA, J.

Inventor name: WATTS, ALAN, D.

Inventor name: LEE, CAROL, M., Y.

DAX Request for extension of the european patent (deleted)
RIN1 Information on inventor provided before grant (corrected)

Inventor name: CORBETT, MELISSA

Inventor name: WATTS, ALAN, D.

Inventor name: SIMPSON, RAINA, J.

Inventor name: PILKINGTON, GLENN, R.

Inventor name: WHITTAKER, JASON, S.

Inventor name: LEE, CAROL, M., Y.

Inventor name: BOEHM, INGRID

Inventor name: JACKSON, STUART

Inventor name: PRIEST, JOHN D

Inventor name: DOMAGALA, TERESA A

Inventor name: LIDDELL, CATHERINE A

A4 Supplementary search report drawn up and despatched

Effective date: 20080915

17Q First examination report despatched

Effective date: 20090107

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090519